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Vitamin E treatment of experimental glomerular disease in rats. tween kidney glomerular sclerosis and atherosclerosis.
Background. Kidney mesangial cells (MCs) and vascular Vitamin E appears beneficial in the prevention and treat-
smooth muscle cells (VSMCs) are closely related in terms of ment of coronary disease and also inhibits the prolifera-origin, microscopic anatomy, histochemistry, and contractility.
tion of VSMCs in vitro [2]. We used vitamin E to treatThis relationship suggests a similarity between kidney glomeru-
glomerular sclerosis and MC-proliferative glomerulone-lar sclerosis and atherosclerosis. Vitamin E appears beneficial
in the prevention and treatment of coronary heart disease and phritis (GN) in two animal models of glomerular disease.
it also inhibits the proliferation of VSMCs in vitro. Thus, we Using rats, a remnant kidney model accelerated with
investigated the effect of vitamin E on glomerular sclerosis and hyperlipidemia was employed to reflect progressive glo-MC-proliferative glomerulonephritis (GN) in two rat models of
merular sclerosis leading to chronic renal failure, and anglomerular disease.
anti-thymocyte serum treatment was used to model acuteMethods. A remnant kidney rat model accelerated with hy-
perlipidemia was used to examine progressive glomerular scle- MC-proliferative GN (anti-Thy-1 GN).
rosis leading to chronic renal failure. A rat model of MC-
proliferative GN was induced by the intravenous administra-
tion of absorbed rabbit anti-rat thymocyte serum (ATS). METHODS
Results. In the remnant kidney rat model, dietary supple-
Remnant kidney modelmentation with vitamin E (500 IU dl-a-tocopheryl acetate/kg)
and cholesterol (2%) significantly inhibited glomerular sclero- Three-month-old male Sprague-Dawley rats (Charles
sis and macrophage infiltration in glomeruli relative to controls River Breeding Laboratory, Kingston, NY, USA) werereceiving basal and cholesterol-supplemented diets. In the
randomly divided to receive three dietary treatments:ATS-induced GN model, glomerular cell proliferation (princi-
(a) a control group (N 5 12) receiving semisyntheticpally MCs) was lower in rats fed diets supplemented with
vitamin E (1000 IU dl-a-tocopheryl acetate/kg) compared with AIN-76A diet (Dyets Inc., Bethlehem, PA, USA); (b)
controls fed the basal diet only. Although the degree of glomer- a 2% cholesterol control group (N 5 12) receiving the
ular macrophage infiltration was similar in both groups, fewer cholesterol supplement in the basal AIN-76A diet; andproliferative cell nuclear antigen (PCNA)-positive cells were
(c) a vitamin E treatment group (N 5 12) fed a 2%observed in the vitamin E group, suggesting that MC prolifera-
tion was suppressed via the inhibition of intracellular transduc- cholesterol AIN-76A diet supplemented with 500 IU
tion. dl-a-tocopheryl acetate/kg diet (Bio-Serv, Frenchtown,
Conclusions. Supplemental dietary vitamin E suppresses NJ, USA). After four weeks of dietary treatment, elec-
MC proliferation and glomerular sclerosis in models of glomer-
trocautery of the right renal cortex was achieved with aular disease in rats. This action of vitamin E in experimental
Surgitront electrocoagulator (Ellman Internationalnephritis suggests the value of clinical trials testing the potential
benefit of vitamin E in chronic GN patients. Manufacturing Inc., Hewlett, NY, USA) according to
Boudet et al [3]. Following a seven-day recovery period,
a left nephrectomy was performed. Rats were sacrificed
Kidney mesangial cells (MCs) and vascular smooth eight weeks later by terminal exsanguination following
muscle cells (VSMCs) are closely related in terms of anesthesia with isofluorane. The kidney remnant was
origin, microscopic anatomy, histochemistry, and con- removed, with a portion prepared for histological exami-
tractility [1]. This relationship suggests a similarity be- nation and the remainder frozen in liquid nitrogen and
stored at 2708C for vitamin E analysis.
Histological examination of the remnant kidney wasKey words: vitamin E, macrophage, mesangial cell proliferation, glo-
merulosclerosis, remnant kidney, anti-thymocyte serum nephritis. conducted in a blinded fashion with light microscopy
using periodic acid-Schiff (PAS) staining of formalin- 1999 by the International Society of Nephrology
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fixed tissue sections to assess glomerulosclerosis. Fifty using PC10 antibody (DAKO A/S, Glostrup, Denmark),
a murine monoclonal antibody to the proliferative cellglomeruli per rat were examined, and the number of
glomeruli showing segmental sclerosis was expressed as a nuclear antigen (PCNA). To quantitate proliferating
cells and macrophage population in glomeruli, the meanpercentage (GSS score) of the total number of glomeruli
counted for each rat. Glomerular macrophage subpopu- number of PCNA-positive or ED-1–positive cells in 30
glomerular cross sections was determined with the histo-lations were examined by immunoenzymatic staining of
ethanol-fixed tissue sections using the Vectastain ABC logical analysis performed in a blinded fashion.
kitt (Vector Laboratories Inc., Burlingame, CA, USA)
Vitamin E analysisand a murine monoclonal ED-1 antibody against rat
monocytes and macrophages (Chemicon International The vitamin E content of the kidney cortex was mea-
sured by reverse-phase high-performance liquid chroma-Inc., Temecula, CA, USA). The number of glomeruli
having ED-1–positive cells was expressed as a percentage tography according to Meydani et al [5].
of the total number of glomeruli counted for each rat.
Urine protein assay
Anti-thymocyte serum model Urine protein concentration was determined using the
Bio-Rad Protein Assay (Bio-Rad Laboratories, Her-Four-week-old male Brown Norway-Fisher 344 F1 hy-
brid rats (BN/F344 rats) from the National Institute of cules, CA, USA).
Aging colony (HSD, Indianapolis, IN, USA) were ran-
Statistical analysisdomly divided into the two diet groups: (a) a control
group (N 5 21) fed a NIH-31 diet (Harlan TekLad, All data are expressed as mean 6 sd. Comparisons
between groups were assessed by using analysis of vari-Madison, WI, USA) containing 17 IU dl-a-tocopheryl
acetate/kg diet (Amersham Pharmacia Biotech, Arlington ance followed by the Student’s t-test. Differences were
considered significant when P , 0.05.Heights, IL, USA); and (b) a vitamin E-supplemented
diet group (N 5 21) fed a NIH-31 diet supplemented
with 1000 IU dl-a-tocopheryl acetate/kg diet.
RESULTS
The anti-Thy-1 GN model is induced by injection of
Remnant kidney modelan antibody to the Thy-1.1 antigen [anti-rat thymocyte
serum (ATS)], which is present on the surface of rat The dietary intervention did not affect the weight gain
or the final body weights of the rats (controls 465 6 28 g;MCs. Absorbed rabbit ATS was prepared by Inter-Cell
Technologies (Hopewell, NJ, USA). Briefly, ATS was cholesterol-supplemented controls 451 6 23 g; vitamin
E treatment 461 6 29 g). The a-tocopherol content ofprepared by immunizing rabbits with BN/F344 rat thy-
mocytes. ATS was then absorbed three times with the renal cortex in the vitamin E treatment group was
52% greater than in the cholesterol-supplemented con-packed BN/F344 rat erythrocytes and three times with
a crude BN/F344 rat liver membrane fraction [4]. The trol group (17.8 6 3.4 vs. 11.7 6 3.3 ng/mg wet wt,
respectively, P , 0.001). Cholesterol supplementationrats were fed their respective diet for eight weeks, and
then ATS (0.5 ml/100 g/body wt) was administered intra- of the diet increased GSS by 244% relative to the control
rats. This effect of cholesterol was reduced 20% by vita-venously. A pilot study revealed the number of glomeru-
lar cells decreased markedly two days following ATS min E treatment. Cholesterol supplementation increased
the glomerular macrophage subpopulation by 144% rela-injection and then increased after six days. Thus, the
rats were sacrificed by terminal exsanguination following tive to the control rats. This effect was reduced by 42%
by vitamin E. At eight weeks postnephrectomy, 24-hourCO2 anesthesia at zero (N 5 7), two (N 5 7), or six days
(N 5 7) after ATS injection. The kidneys were removed urinary protein excretion was not different between the
groups (controls 110 6 24 mg/day; cholesterol-supple-with a portion prepared for histological examination and
the remainder frozen in liquid nitrogen and stored at mented controls 93 6 43 mg/day; vitamin E treatment
101 6 21 mg/day). Modest increases in serum low-density2708C for vitamin E analysis.
Kidney tissue was fixed in 10% formalin, and 3 mm lipoprotein (LDL) and very LDL (VLDL) were ob-
served in rats fed the cholesterol-supplemented controlparaffin sections were stained with PAS for histological
examination by light microscopy. The total number of diet (data not shown).
nuclei per glomerular cross section was counted in 30
Anti-thymocyte serum modelglomeruli to provide a semiquantitative assessment of
glomerular cellularity. Glomerular macrophage subpop- The dietary intervention did not affect the weight gain
or the final body weights of the rats (controls 268 6ulations were examined by immunoenzymatic staining
using a murine ED-1 monoclonal antibody against rat 23 g; vitamin E treatment 256 6 15 g). The a-tocopherol
content of the renal cortex in the vitamin E-treated ratsmonocytes and macrophages. Proliferating cell subpopu-
lations were also examined by immunoenzymatic staining at day 0 was 165% greater than controls (24.4 6 2.5 vs.
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monoclonal antibodies, has been observed in atheroscle-
rotic lesions from humans and experimental animals,
including in the glomeruli of cholesterol-fed nephrotic
rats [8]. Furthermore, the lesions of glomerulosclerosis in
rats with subtotal nephrectomy resemble atherosclerotic
lesions [1]. Thus, oxidized LDL may play an important
role in the pathogenesis of chronic renal failure associ-
ated with hypercholesterolemia. The slight elevation in
serum LDL 1 VLDL observed in the cholesterol-supple-
mented rats might contribute to increase in LDL oxida-
tion in the kidney and enhance the infiltration of macro-
phages into glomeruli. The production of reactive oxygen
species by activated macrophages could further increase
lipid peroxidation of polyunsaturated fatty acids in cell
membranes and the glomerular injury observed in the
remnant kidney model as a higher GSS score. Thus, the
Fig. 1. Effect of vitamin E on glomerular cell proliferation in anti- action of supplementary vitamin E in the remnant kidneyThy-1 glomerulonephritis. Symbols are: (h) control; ( ) vitamin E.
to reduce macrophage infiltration into glomeruli and*P , 0.0001 vs. control at day 6.
ameliorate the progression of glomerular sclerosis may
be related to its antioxidant function and inhibition of
LDL oxidation.
9.2 6 1.2 ng/mg wet wt, P , 0.0001). The a-tocopherol The ATS (anti-Thy-1) rat model of acute MC-prolifer-
content in the renal cortex at day 2 or 6 was not signifi- ative GN presents with a rapid, complement-dependent
cantly different from that at day 0. The glomerular total loss of MCs with disruption of the mesangial matrix
cell number in both control and vitamin E treatment (mesangiolysis). Early mesangiolysis occurs one to two
groups decreased two days after ATS injection. Six days days after ATS injection and is followed by marked MC
after ATS injection, the glomerular cell number rose in proliferation and expansion of the mesangial extracellu-
the controls. However, glomerular cell proliferation in lar matrix after four days. MC proliferation is prominent
the vitamin E group was significantly suppressed by 19% after one to two weeks. Although the pathogenic events
compared with the control group at day 6 (Fig. 1). The in this model have not been fully elucidated, it appears
number of infiltrated macrophages, that is, ED-1– that after MC injury, macrophages infiltrate the glomer-
positive cells, in glomeruli reached a peak at day 2. The uli and produce growth factors and cytokines that stim-
control and vitamin E groups showed similar increases ulate the MC proliferation. We observed fewer total
in macrophage number in the glomeruli (Fig. 2A). The glomerular cells and PCNA-positive proliferating glo-
number of proliferating cells, that is, PCNA-positive merular cells six days post-ATS treatment in rats treated
cells, in glomeruli increased by day 2, with further in- with vitamin E, although the number of macrophages in
creases noted by day 6. The increase in proliferating cells glomeruli was not different from controls. These results
was significantly lower in the vitamin E group at day 6 suggest that MC proliferation was being suppressed by
day 6.relative to the control group (Fig. 2B). Slight increases
The suppression of MC proliferation induced by vita-in 24-hour urinary protein excretion were noted in both
min E in the ATS model appears unrelated to a protec-groups after ATS administration, but no difference be-
tive action against MC injury, as the number of recruitedtween groups was observed (4.0 6 0.7 vs. 4.4 6 1.1 mg/
macrophages into glomeruli were similar at day 2 inday at day 0 and 12.8 6 7.6 vs. 10.1 6 2.0 mg/day at day 6
both the control and treatment groups. Interestingly,in control and vitamin E treatment groups, respectively).
Boscoboinik et al reported that vitamin E reduces VSMC
proliferation by inhibiting protein kinase C activity [2].
DISCUSSION They also noted that VSMC proliferation was stimulated
Reactive oxygen species appear to be involved in the by platelet-derived growth factor (PDGF) or endothelin
pathogenesis of the remnant kidney model. The rate of (ET), events inhibited by vitamin E. PDGF and ET ap-
oxygen consumption in nephrons increases approxi- pear to be the principal cytokines involved in MC prolif-
mately threefold after subtotal renal ablation [6]. In addi- eration in the ATS model. Thus, vitamin E may suppress
tion, renal cortical malondialdehyde, a product of lipid MC proliferation via the inhibition of the intracellular
peroxidation, increases progressively in the remnant kid- signal transduction pathway, for example, those regulat-
ney model [7]. Oxidatively modified LDL acts as a mac- ing protein kinase C. However, one cannot yet exclude
the possibility that vitamin E modulates the ability ofrophage chemoattractant and, detected with specific
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Fig. 2. Effects of vitamin E on (A) glomerular macrophage and (B) proliferating (PCNA-positive) cell subpopulation in anti-Thy-1 glomerulonephri-
tis. Symbols are: (h) control; ( ) vitamin E. *P , 0.05 versus control at day 6.
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